ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

1.85
-1.12
(-37.71%)
Closed November 18 4:00PM
1.80
-0.05
( -2.70% )
Pre Market: 7:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.80
Bid
1.71
Ask
2.35
Volume
334
0.00 Day's Range 0.00
1.62 52 Week Range 5.29
Previous Close
1.85
Open
-
Last Trade
20
@
2.51
Last Trade Time
06:03:49
Average Volume (3m)
118,861
Financial Volume
-
VWAP
-

DWTX Latest News

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.61-47.21407624633.413.761.62551602.47675748CS
4-2.08-53.60824742273.885.151.62509773.83989431CS
12-1.75-49.29577464793.555.291.621188613.93442883CS
26-1.75-49.29577464793.555.291.621188613.93442883CS
52-1.75-49.29577464793.555.291.621188613.93442883CS
156-1.75-49.29577464793.555.291.621188613.93442883CS
260-1.75-49.29577464793.555.291.621188613.93442883CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRFXPainReform Ltd
$ 1.40
(161.68%)
32.94M
NCNCnoco noco Inc
$ 0.2171
(123.81%)
73.58M
ALCEAlternus Clean Energy Inc
$ 2.55
(61.39%)
4.25M
SMCXDefiance Daily Target 2X Long SMCI ETF
$ 37.37
(46.43%)
264.13k
CTRNCiti Trends Inc
$ 22.97
(40.70%)
40
CBLLCeriBell Inc
$ 12.11
(-51.56%)
101
XNCRXencor Inc
$ 14.11
(-39.15%)
9
UPBUpstream Bio Inc
$ 14.51
(-38.96%)
104
AXGNAxogen Inc
$ 9.50
(-25.78%)
99
IBCPIndependent Bank Corporation
$ 28.25
(-23.65%)
5
NCNCnoco noco Inc
$ 0.2171
(123.81%)
73.58M
PRFXPainReform Ltd
$ 1.40
(161.68%)
32.94M
TFFPTFF Pharmaceuticals Inc
$ 0.4222
(15.99%)
17.94M
HCWBHCW Biologics Inc
$ 1.58
(27.42%)
15.63M
SMCISuper Micro Computer Inc
$ 26.49
(22.98%)
9.52M

Your Recent History

Delayed Upgrade Clock